IntraBio
About IntraBio
IntraBio is a biotechnology company focused on discovering, developing, and commercializing novel therapies for rare and neurodegenerative diseases with high unmet medical needs. The company emphasizes lead programs and mechanism of action insights to advance therapeutics through research and clinical development. Its activities span from drug discovery and translational science to clinical trials and publications, aiming to bring targeted treatments to patients with limited options. The organization positions itself as a leader in rare disease therapeutics, with progress and collaborations highlighted on its website.
Recent News
IntraBio Reports the US FDA’s sNDA Submission of Aqneursa for Ataxia-Telangiectasia
IntraBio Says Rare Disease Drug Passes Phase 3, Will Seek FDA Approval
IntraBio Receives Regulatory Authorization to Begin Pivotal Phase III Trial of Levacetylleucine in CACNA1A-Related Disorders Across Participating Regions
Recent Deals
No recent deals for this company.